Diagnostic News and Research

RSS

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

A novel diagnostic test to rapidly detect neutrophil gelatinase-associated lipocalin (NGAL), an early biomarker that identifies patients at risk for acute kidney injury (AKI), has been accepted for review by the United States Food and Drug Administration. If approved, this would be the first test available for use in the United States for the detection of NGAL.

1 Apr 2010

IGEN Networks signs MOU with Bio Business Development

IGEN Networks Corp. is pleased to announce that it has signed a memorandum of understanding with Bio Business Development Corp. International, Inc. to negotiate the acquisition of the exclusive global distribution rights to the patented lateral-flow diagnostic testing platform technology for rapid detection of the infectious prion protein diseases.

1 Apr 2010

Cardiac CT can help identify and predict at risk heart attack patients

One of the largest research studies into cardiac computed tomography (CT), conducted at the University of Ottawa Heart Institute (UOHI), shows that the high-speed advanced imaging technology can identify and predict patients at risk for heart attack and death.

1 Apr 2010

BioCision, Biohit announce co-promotion program

BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.

31 Mar 2010

FDA clears AdvanDx' 90 minutes protocol for C. albicans PNA FISH and C. albicans/C. glabrata PNA FISH tests

AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.

31 Mar 2010

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

31 Mar 2010

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31, 2009.

31 Mar 2010

BIO pleased with Court's dismissal of claims over patenting gene-based inventions

“As explained in the ruling yesterday, the District Court's determination is only a preliminary step in the legal process that does not affect how the U.S. Patent and Trademark Office (PTO) evaluates patent applications relating to DNA-based inventions.”

31 Mar 2010

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.

31 Mar 2010

Signostics raises $5M in oversubscribed round of financing from new and existing investors

Signostics Inc., a U.S. and Australian-based medical device company developing revolutionary and affordable palm-sized ultrasound devices, has raised $5 million in an oversubscribed round of financing from new and existing investors. The company has raised a total of $19 million to date.

31 Mar 2010

Evergreen Hospital Medical Center plans open new ED in Redmond

Evergreen Hospital Medical Center announced plans today to open a Redmond Emergency Department. Hospital leaders and physicians say the new ED will give area residents improved access to round-the-clock health care.

31 Mar 2010

Despite stagnant economy, total employment in Ohio's bioscience sector increased by 2.8%

Employment in Ohio's biosciences sector is on the rise across the state according to a report released today by BioOhio, a non-profit organization supported by the Thomas Edison Program of the Ohio Department of Development.

31 Mar 2010

PMDD often misdiagnosed as major depression or other mood disorder

As science slowly, but continually, unravels the causes of disorders, it increasingly teases apart biological threads that, when spooled together, begin to take on the warp and weft of separate disorders.

31 Mar 2010

Devicor offers to acquire EES Breast Care business

Ethicon Endo-Surgery, Inc. (EES), a Johnson & Johnson company, today announced it has received an irrevocable, unconditional offer from Devicor Medical Products (Devicor), a portfolio company of GTCR Golder Rauner, LLC, (GTCR), to acquire its Breast Care business. The EES Breast Care business sells products designed to help doctors diagnose breast cancer at early stages, while minimizing patient discomfort. Financial terms of the offer are not being disclosed.

31 Mar 2010

NMS Labs launches test to evaluate the efficacy of Milnacipran

NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring of individual patients, and the assessment of drug diversion of a new pain management drug therapy.

31 Mar 2010

Investment report on Fonar from InvestorSoup.com

InvestorSoup.com announces an investment report featuring Fonar Corp. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

30 Mar 2010

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Modular Building Institute has named MedBuild, a healthcare division of ModSpace, first-place winner for their 2010 Awards of Distinction. MBI gave MedBuild top honors in its permanent healthcare category for its construction of the patient-ready imaging suite at Nash General Hospital in Rocky Mount, N.C.

30 Mar 2010

Plaques in blood vessels may break by overproducing protein-digesting enzymes

University of Washington (UW) researchers have gathered evidence that dangerous plaques in blood vessels can rupture by overproducing protein-digesting enzymes. Plaques are fat-laden rough spots in the otherwise smooth walls of arteries. When a plaque ruptures, blood accumulates inside of it, a process known as plaque hemorrhage. The plaque enlarges and artery-blocking clots can form. If the flow of oxygen-rich blood is restricted, a heart attack, stroke, or damage to other organs can occur.

30 Mar 2010

New DNA test to detect Lyme disease spirochete infection

Many of the more than 30,000 people a year in the United States with suspected cases of Lyme disease spirochete (bacterial) infection can now take a DNA test developed by a Connecticut scientist/physician and his team that can quickly determine if they test positive for Lyme spirochetes in their blood.

30 Mar 2010

In pregnant women, DVT more likely to occur on left side

Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.

30 Mar 2010

Diagnostic News and Research

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

IGEN Networks signs MOU with Bio Business Development

Cardiac CT can help identify and predict at risk heart attack patients

BioCision, Biohit announce co-promotion program

FDA clears AdvanDx' 90 minutes protocol for C. albicans PNA FISH and C. albicans/C. glabrata PNA FISH tests

Rosetta Genomics reports revenues of $150,000 for full-year 2009

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

BIO pleased with Court's dismissal of claims over patenting gene-based inventions

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

Signostics raises $5M in oversubscribed round of financing from new and existing investors

Evergreen Hospital Medical Center plans open new ED in Redmond

Despite stagnant economy, total employment in Ohio's bioscience sector increased by 2.8%

PMDD often misdiagnosed as major depression or other mood disorder

Devicor offers to acquire EES Breast Care business

NMS Labs launches test to evaluate the efficacy of Milnacipran

Investment report on Fonar from InvestorSoup.com

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Plaques in blood vessels may break by overproducing protein-digesting enzymes

New DNA test to detect Lyme disease spirochete infection

In pregnant women, DVT more likely to occur on left side

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News